LighthouseAI Raises $8M Series A for Pharma Compliance
LighthouseAI, a U.S.-based provider of AI-powered software and services for pharmaceutical supply chain compliance, has raised $8M in Series A funding led by Boxcars Ventures. The platform automates license tracking, regulatory surveillance across 50 states, DC, and Puerto Rico, and handles filings and renewals. The capital will fuel product development, including expansions to Rapid Assessments, and team growth to support enterprise customers.
AI RegTech Funding Heats Up
The round comes amid rising investment in AI-driven compliance tools. Flinn.ai raised $20M Series A in February 2026 for similar regulatory automation in pharma and medtech. LighthouseAI's focus on state licensing fills a niche gap in end-to-end pharma supply chain management, differentiating from broader RegTech players.
DSCSA Deadlines Amplify Risks
Pharma supply chain firms face mounting regulatory pressures from the Drug Supply Chain Security Act (DSCSA), with full enforcement set for November 2026 per NCPA. State boards issue frequent changes, such as updates in Maine, South Carolina, and Oregon in early 2026. Traditional manual processes lead to 10-15% non-compliance rates in state licensing due to overlooked facility details and scattered agency data.
Rapid Assessments Slash Research Time
LighthouseAI's Intelligence® scans 200+ agencies for real-time regulatory changes, while Management® handles tasks, documents, and alerts. The newly launched Rapid Assessments uses AI to deliver compliance requirements across 55 jurisdictions instantly, cutting weeks of manual research to seconds. This hybrid of SaaS and expert services outperforms pure service competitors like State License Servicing.
As Sumeet Singh, Founder and CEO, noted:
"This funding allows us to continue the growth we've worked for. We are grateful for the dedication of our employees and the loyalty of our customers."
Boxcars Validates Pharma Niche
Boxcars Ventures led the round with participation from TGVP and existing investors, signaling conviction in LighthouseAI's post-seed trajectory after a $4.6M raise in 2023. The investment arrives as the company reports profitability in Q4 2025 and doubled its customer base to 250 since January 2025. This mix of growth capital and strategic backers positions LighthouseAI for deeper enterprise penetration.
Compliance Market Scales Rapidly
The pharmaceutical compliance software market stands at $463M in 2025, projected to reach $1.04B by 2034 at a 9.45% CAGR according to 360 Research Reports. Alternative estimates peg it at $0.5B with 9.86% CAGR per Business Research Insights. Tailwinds include DSCSA mandates and accelerating state regulations, driving automation demand.
Exits Build Domain Expertise
Founder Sumeet Singh spun LighthouseAI from Pharma Solutions, following successful exits at Excel Health Logistics and Pharma Solutions. Team members bring multiple wins: Douglas Edmunds led a NASDAQ IPO at WELLGISTICS and exited Black Bay Data; Nick Reutell scaled HealthCrowd through acquisition. This track record in pharma ops, compliance, and SaaS scaling underpins execution credibility.
Enterprise Hires Drive Expansion
Post-funding, LighthouseAI appointed Bill Versosky as Chief Commercial Officer with 25+ years leading $1.5B sales orgs and Vicki J. Camden as VP Trade Relations with 35+ years in pharma. The firm doubled headcount to 85 employees and serves 15+ enterprises over $1B revenue, processing $12B+ in transactions. Plans target further product updates like Notifications 2.0 and conference presence to capture market share.